PKP2 and arrhythmogenic right ventricular cardiomyopathy: This study demonstrated that ARVC clinical phenotypes, recapitulated by a mouse model, (1) were largely preventable before the onset of cardiomyopathy and (2) can be attenuated after the onset of disease by exogenous restoration of PKP2 expression.